[HTML][HTML] BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
Objectives The mRNA coronavirus disease 2019 (COVID-19) vaccines have shown high
effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease and …
effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease and …
[HTML][HTML] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
…, EG Levin, T Hod, C Cohen, Y Lustig, G Rahav - Clinical Microbiology …, 2021 - Elsevier
Objectives The immunogenicity and safety of the Pfizer-BioNTech BNT162b2 mRNA vaccine
in people living with human immunodeficiency virus type 1 (PLWH) are unknown. We …
in people living with human immunodeficiency virus type 1 (PLWH) are unknown. We …
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3 …
…, DP Kontoyiannis, OA Cornely, EJ Bow, G Rahav… - The Lancet, 2016 - thelancet.com
Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The
SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients …
SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients …
[HTML][HTML] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
…, R Nathan, T Birch, OA Cornely, G Rahav… - … England Journal of …, 2017 - Mass Medical Soc
Background Clostridium difficile is the most common cause of infectious diarrhea in
hospitalized patients. Recurrences are common after antibiotic therapy. Actoxumab and …
hospitalized patients. Recurrences are common after antibiotic therapy. Actoxumab and …
Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk
…, M Deutch, E Elbaz, H Genaim, G Rahav… - JAMA network …, 2021 - jamanetwork.com
Importance Allergic reactions among some individuals who received the Pfizer-BioNTech (BNT162b2)
COVID-19 vaccine discourage patients with allergic conditions from receiving this …
COVID-19 vaccine discourage patients with allergic conditions from receiving this …
An Outbreak of Phialemonium Infective Endocarditis Linked to Intracavernous Penile Injections for the Treatment of Impotence
J Strahilevitz, G Rahav, HJ Schroers… - Clinical infectious …, 2005 - academic.oup.com
Background . In March 2002, a patient in Tel Aviv, Israel, died of endocarditis caused by
Phialemonium curvatum. As part of his therapy for erectile dysfunction, the patient had been …
Phialemonium curvatum. As part of his therapy for erectile dysfunction, the patient had been …
Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children
…, M Raz, Y Carmeli, B Shainberg, E Derazne, G Rahav… - Jama, 2004 - jamanetwork.com
ContextWidespread pneumococcal conjugate vaccination may bring about epidemiologic
changes in upper respiratory tract flora of children. Of particular significance may be an …
changes in upper respiratory tract flora of children. Of particular significance may be an …
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
…, I Oren, PG Pappas, Z Ráčil, G Rahav… - The Lancet infectious …, 2016 - thelancet.com
Background Mucormycosis is an uncommon invasive fungal disease with high mortality and
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …
few treatment options. Isavuconazole is a triazole active in vitro and in animal models …
[HTML][HTML] Utilization of machine-learning models to accurately predict the risk for critical COVID-19
…, A Epstein, R Mor-Cohen, A Biber, G Rahav… - Internal and emergency …, 2020 - Springer
Among patients with Coronavirus disease (COVID-19), the ability to identify patients at risk
for deterioration during their hospital stay is essential for effective patient allocation and …
for deterioration during their hospital stay is essential for effective patient allocation and …
[HTML][HTML] Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO …
…, EJ Giamarellos-Bourboulis, G Rahav… - Infectious diseases and …, 2018 - Springer
Methods A total of 77 patients with confirmed/suspected CRE infection (bacteremia, hospital-acquired/ventilator-associated
bacterial pneumonia, complicated intra-abdominal infection, …
bacterial pneumonia, complicated intra-abdominal infection, …